Spero Therapeutics
SPRO
SPRO
55 hedge funds and large institutions have $119M invested in Spero Therapeutics in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
Holders
55
Holding in Top 10
2
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$5.38M | |
| 2 | +$2.71M | |
| 3 | +$747K | |
| 4 |
AIC
AWM Investment Company
New York
|
+$406K |
| 5 |
BlackRock
New York
|
+$291K |
Top Sellers
| 1 | -$4.06M | |
| 2 | -$1.05M | |
| 3 | -$1.03M | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$626K |
| 5 |
State Street
Boston,
Massachusetts
|
-$456K |